Ozempic and Wegovy dosing mistakes behind thousands of poison control calls

Calls to US poison control centres involving semaglutide (Ozempic and Wegovy) soared after the drug was approved for weight management. Researchers found that the increase was driven by accidental dosing mistakes rather than intentional misuse. Basic patient education about the weekly dosing schedule and gradual dose escalation could prevent most of these avoidable incidents.